Literature DB >> 10205218

Hepatic and splanchnic nitric oxide activity in patients with cirrhosis.

A I Sarela1, F M Mihaimeed, J J Batten, B R Davidson, R T Mathie.   

Abstract

BACKGROUND: In animal models of cirrhosis, altered activity of nitric oxide (NO) has been implicated in the pathogenesis of increased intrahepatic portal vascular resistance and abnormal mesenteric vasodilatation. AIMS: To investigate NO activity in the liver and splanchnic vascular bed of patients with cirrhosis.
METHODS: Activity of the calcium dependent constitutive and calcium independent inducible isoforms of NO synthase (cNOS and iNOS, respectively) was assayed biochemically in biopsy specimens of liver and a vascular portion of the greater omentum (representative of mesenteric vasculature) obtained from patients with cirrhosis undergoing liver transplantation (n=14) and non-cirrhotic control patients undergoing liver resection for metastases (n=9). The concentration of NO metabolites (NO2 + NO3) in portal and peripheral venous plasma was measured.
RESULTS: The activity of cNOS was lower in cirrhotic compared with non-cirrhotic subjects for both liver and omentum. Hepatic and omental iNOS activities did not differ significantly between the two groups. Portal (NO2 + NO3) was threefold higher in cirrhotic than non-cirrhotic patients, but no differences were observed in systemic venous samples from the two groups.
CONCLUSIONS: The activity of cNOS is diminished in the cirrhotic human liver. The resultant decrease in constitutive NO release may promote an increase in the intrahepatic portal vascular resistance. Elevated portal venous (NO2 + NO3) indicates enhanced splanchnic vascular release of NO in cirrhotic patients, but the absence of increased NOS activity in the mesenteric vasculature suggests differential regulation of NO synthesis within the splanchnic vascular bed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205218      PMCID: PMC1727519          DOI: 10.1136/gut.44.5.749

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  44 in total

1.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme.

Authors:  D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

3.  Plasma levels of atrial natriuretic peptide in cirrhotic patients.

Authors:  A Fernández-Cruz; J Marco; L M Cuadrado; J Gutkowska; D Rodríguez-Puyol; C Caramelo; J M López-Novoa
Journal:  Lancet       Date:  1985 Dec 21-28       Impact factor: 79.321

4.  Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.

Authors:  D C Rockey; J J Chung
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

5.  Vasoactive intestinal polypoptide: inactivation in liver and potentiation in lung of anesthetized dogs (384699).

Authors:  S Kitamura; T Yoshida; S I Said
Journal:  Proc Soc Exp Biol Med       Date:  1975-01

6.  Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver.

Authors:  C Caramelo; S Fernández-Gallardo; J C Santos; P Iñarrea; M Sánchez-Crespo; J M López-Novoa; L Hernando
Journal:  Eur J Clin Invest       Date:  1987-02       Impact factor: 4.686

7.  Increased nitric oxide activity in a rat model of acute pancreatitis.

Authors:  R A Al-Mufti; R C Williamson; R T Mathie
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.

Authors:  R D Zipser; J C Hoefs; P F Speckart; P K Zia; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

9.  Role of glucagon in splanchnic hyperemia of chronic portal hypertension.

Authors:  J N Benoit; B Zimmerman; A J Premen; V L Go; D N Granger
Journal:  Am J Physiol       Date:  1986-11

10.  Evidence for tumour necrosis factor/cachectin production in cancer.

Authors:  F Balkwill; R Osborne; F Burke; S Naylor; D Talbot; H Durbin; J Tavernier; W Fiers
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

View more
  19 in total

1.  Distribution of nitric oxide synthase in normal and cirrhotic human liver.

Authors:  Lance McNaughton; Lakshmi Puttagunta; Maria Angeles Martinez-Cuesta; Norm Kneteman; Irvin Mayers; Redwan Moqbel; Qutayba Hamid; Marek W Radomski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-13       Impact factor: 11.205

Review 2.  Treatment Barriers in Portopulmonary Hypertension.

Authors:  Batool AbuHalimeh; Michael J Krowka; Adriano R Tonelli
Journal:  Hepatology       Date:  2018-12-18       Impact factor: 17.425

3.  Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats.

Authors:  Xin Wang; Yue-Xia Zhong; Zong-You Zhang; Ju Lu; Mei Lan; Ji-Yan Miao; Xue-Gang Guo; Yong-Quan Shi; Yan-Qiu Zhao; Jie Ding; Kai-Cun Wu; Bo-Rong Pan; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.

Authors:  M Van de Casteele; A Omasta; S Janssens; T Roskams; V Desmet; F Nevens; J Fevery
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 5.  Stellate cell contraction: role, regulation, and potential therapeutic target.

Authors:  Russell K Soon; Hal F Yee
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

6.  Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

Authors:  R P Mookerjee; S Sen; N A Davies; S J Hodges; R Williams; R Jalan
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 7.  Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.

Authors:  Paloma Lluch; Gloria Segarra; Pascual Medina
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

8.  Therapeutic potential of targeting the renin angiotensin system in portal hypertension.

Authors:  Chandana B Herath; Josephine A Grace; Peter W Angus
Journal:  World J Gastrointest Pathophysiol       Date:  2013-02-15

9.  Nitric oxide synthase and heme oxygenase expressions in human liver cirrhosis.

Authors:  Beatrice J Goh; Bee Tee Tan; Wei Min Hon; Kang Hoe Lee; Hoon Eng Khoo
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

Review 10.  Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

Authors:  Massimo Bolognesi; Marco Di Pascoli; Alberto Verardo; Angelo Gatta
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.